Status and phase
Conditions
Treatments
About
This study aims to investigate the effect of involved-field radiotherapy for recurrent ovarian cancer after primary standard treatment. We will investigate whether the addition of involved-field RT improves 2-year PFS in those patients than that of historical data (only with other standard salvage treatments as systemic chemotherapy ± maximum tumor resection).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
If, all in lung, or intra-abdominal or pelvis organs - ≤ 5 If, any in liver, bone, or spinal cord - ≤ 2
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
107 participants in 1 patient group
Loading...
Central trial contact
Yong Bae Kim, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal